Weighing the Effects of Immunosuppression for Hyperinflammation in COVID-19
The effects of reducing hyperinflammation by immunosuppression has been discussed in this editorial.
Immunosuppression
Biologics Use Not Associated With Increased Mortality or Readmission Risk After Major Surgery in RA
Researchers evaluated the effect of biologics and glucocorticoids on outcomes after major surgeries in rheumatoid arthritis.
Immunosuppressants Effective for Early Diffuse Cutaneous Systemic Sclerosis Treatment
Prospective, observational study assessed 4 treatment protocols and their effects on skin thickening.
Frequency of Hepatitis B Reactivation in Rheumatoid Arthritis
Results confirm that low baseline hepatitis B surface antibody titers are significant risk factors for HBV reactivation in patients with rheumatoid arthritis.
Trends in Self-Reported Immunosuppression Among Adults in US
The estimated prevalence of current immunosuppression is 2.7% among the US population.
- Loading...
Loading...
Next post in Research
Loading... 
Loading...